- Home
- Publications
- Publication Search
- Publication Details
Title
Trial watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 3, Issue 6, Pages e29030
Publisher
Informa UK Limited
Online
2014-06-04
DOI
10.4161/onci.29030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
- (2014) Nai-Kong V. Cheung et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours
- (2014) Shodeinde A. Coker et al. JOURNAL OF CHEMOTHERAPY
- Report of a Phase I Evaluation of Dose and Schedule of Interleukin-1 Alpha and Cyclophosphamide in Patients with Advanced Tumors: An Eastern Cooperative Oncology Group Study (PX990) and Review of IL-1-Based Studies of Hematopoietic Reconstitution
- (2014) Janice P. Dutcher et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis
- (2014) A. Mortha et al. SCIENCE
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial Watch
- (2014) Jonathan Pol et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models
- (2013) Shu Su et al. Asian Pacific Journal of Cancer Prevention
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
- (2013) Joseph P Connor et al. BMC CANCER
- Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
- (2013) Arash Naeim et al. BMC CANCER
- Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma
- (2013) Charles S. Harmon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response
- (2013) Chiara Camisaschi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
- (2013) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies
- (2013) Giovanni Vitale et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
- (2013) Geok Choo Sim et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
- (2013) Erin E. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma
- (2013) Michael J. Robertson et al. JOURNAL OF IMMUNOTHERAPY
- The Dark Side of Cyclophosphamide: Cyclophosphamide-Mediated Ablation of Regulatory T Cells
- (2013) Jürgen C. Becker et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melatonin improves humoral and cell-mediated immune responses of male golden hamster following stress induced by dexamethasone
- (2013) Dipanshu Kumar Vishwas et al. JOURNAL OF NEUROIMMUNOLOGY
- Drug development: Releasing the brakes
- (2013) Karen Weintraub NATURE
- Immunotherapy at Large: Balancing tumor immunity and inflammatory pathology
- (2013) Glenn Dranoff NATURE MEDICINE
- Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection
- (2013) Pierre Guermonprez et al. NATURE MEDICINE
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Antibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia
- (2013) K. L. Gutbrodt et al. Science Translational Medicine
- Immunosurveillance as a regulator of tissue homeostasis
- (2013) Laura Senovilla et al. TRENDS IN IMMUNOLOGY
- Illuminating somatostatin analog action at neuroendocrine tumor receptors
- (2013) Jean Claude Reubi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
- (2013) Paul Zarogoulidis et al. Drug Design Development and Therapy
- Strong emerging rationale for combining oncogene-targeted agents with immunotherapy
- (2013) Yan Yang et al. OncoImmunology
- Novel multifunctional antibody approved for the treatment of breast cancer
- (2013) Domenico Mavilio et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Inhibiting the inhibitors
- (2013) Domenico Mavilio et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immunogenic cell death in radiation therapy
- (2013) Lorenzo Galluzzi et al. OncoImmunology
- Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan
- (2013) Shakeel Modak et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine
- (2012) T. Pabst et al. BLOOD
- Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors
- (2012) R Omori et al. CANCER GENE THERAPY
- Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
- (2012) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
- (2012) C. Sebban et al. EUROPEAN JOURNAL OF CANCER
- STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma
- (2012) Masatoshi Eto et al. EUROPEAN UROLOGY
- Designing immunoconjugates for cancer therapy
- (2012) Serengulam V Govindan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours
- (2012) G. Spitaleri et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy
- (2012) Kelvin K.W. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- (2012) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma
- (2012) Ahmad A. Tarhini et al. JOURNAL OF IMMUNOTHERAPY
- Combined TLR Stimulation With Pam3Cys and Poly I
- (2012) So Nai Lim et al. JOURNAL OF IMMUNOTHERAPY
- Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: Systematic review of clinical efficacy and quality assessment of reported trials
- (2012) N.H. Trabulsi et al. JOURNAL OF SURGICAL ONCOLOGY
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
- (2012) Niklas Feldhahn et al. OncoImmunology
- Combining targeted therapy with immunotherapy (interferon-α)
- (2012) Lei L. Chen et al. OncoImmunology
- Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
- (2012) Nai-Kong V. Cheung et al. OncoImmunology
- Abscopal but desirable
- (2012) Guido Kroemer et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
- (2011) Jan P. Deroose et al. ANNALS OF SURGICAL ONCOLOGY
- Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
- (2011) J. P. Deroose et al. BRITISH JOURNAL OF SURGERY
- Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo
- (2011) C. M. Hennies et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism
- (2011) C. G. Twitty et al. CLINICAL CANCER RESEARCH
- Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin
- (2011) Daniel M Andrews et al. IMMUNOLOGY AND CELL BIOLOGY
- Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
- (2011) Jan P. Deroose et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor
- (2011) Irene Y. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
- (2010) Lee M. Krug et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- T cell activation upon exposure to patient-derived tumor tissue: A functional assay to select patients for adoptive T cell therapy
- (2010) Caroline Schroten et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
- (2010) Luca Gianni et al. LANCET
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients
- (2010) L. Weiss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant Interferon-based Chemoradiation Followed By Gemcitabine for Resected Pancreatic Adenocarcinoma: A Single-Institution Phase II Study
- (2009) David C. Linehan et al. ANNALS OF SURGERY
- Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
- (2009) M. A. Curran et al. CANCER RESEARCH
- Adjuvant Interferon alfa for melanoma: new evidence-based treatment recommendations?
- (2009) Axel Hauschild Current Oncology
- In This Issue
- (2008) CELL
- SnapShot: Cytokines I
- (2008) Cristina M. Tato et al. CELL
- IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
- (2008) Susan Brandenburg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation